ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000250129.1	AKT inhibitor VIII	Breast invasive carcinoma	0.048550696	Resistant
ENSG00000250129.1	AKT inhibitor VIII	Thyroid carcinoma	0.043715449	Sensitive